Okayama University Research: New Device for Assisting Accurate Hemodialysis Catheter Placement

OKAYAMA, Japan, August 10, 2018 /PRNewswire/ --

Researchers at Okayama University report in The Journal of Vascular Access a supporting device for accurately placing hemodialysis catheters on kidney patients. The device was successfully used on a group of 10 patients and is expected to become an essential tool in situations where other, catheter-free hemodialysis approaches are not possible. 

     (Photo: https://mma.prnewswire.com/media/729185/Okayama_University_TCC.jpg )

Patients with improperly functioning kidneys often need to undergo hemodialysis - the procedure of purifying blood in an artificial kidney outside the body - on a regular basis. Hemodialysis requires access to blood vessels, for the collection of blood and its re-introduction after purification. In this context, vascular access is commonly achieved with a so-called tunneled cuffed catheter (TCC). Accurate TCC placement is important; incorrect positioning can lead to blood clots and induce central vein thrombosis. Assistant Professor Toshiaki Ohara from Okayama University and colleagues have now developed a device enabling accurate TCC placement. The researchers' insertion support device accommodates for individual body shape differences and is expected to decrease the rate of TCC replacements - typically ranging between 8.9% and 56%.

The device was made from a material called expanded polytetrafluoroethylene (ePTFE), having the property of maintained plasticity. It can be described as a bendable ribbon with holes (eyelets) spaced 1 cm apart; the holes allow making markings on the patient's body with a felt-tip pen.

The insertion support device was tested on 10 Japanese adult hemodialysis patients (6 men and 4 women with a mean age of 71.3 years) treated at Shigei Medical Research Hospital. Placement of the device on the body took place with the help of X-ray imaging: the tip of the device, for marking the TCC entry site, was laid so that it overlaps with the right heart border. With the help of the markings made on the patient's body, the physician could insert the TCC within an error of about 1 cm. The patients were observed for 2 months, during which there was no catheter replacement needed.

The device of Dr. Ohara and colleagues helps to reduce catheter waste and the overall cost of hemodialysis. In addition, as the attachment of a catheter requires exposure to X-rays, it reduces accumulated radiation doses for both patients and physicians. Although the study was only carried out for 10 patients in a short observation period, the scientists 'anticipate that this new device can be used for catheter intervention in many fields'.

Background 

Hemodialysis 

Hemodialysis, also known as kidney dialysis or just dialysis, refers to the purification of the blood of a person with malfunctioning kidneys. In hemodialysis, blood is extracted from the body, purified from waste substances such as creatinine and urea, and re-introduced into the blood circulation system.

For blood extraction and re-introduction, access to blood vessels is required. Vascular access is typically realized by an arteriovenous fistula (AVF), an arteriovenous graft (AVG) or a tunneled cuffed catheter (TCC). Access through AVF or AVG - both involve surgically created passageways between an artery and a vein - are generally preferred, because of better prevention of infection. Some patients cannot undergo AVF or AVG, however, because of heart failure or low cardiac reserve (the difference between the heart's pumping rate and its maximum pumping capacity). For these patients, a TCC is the appropriate solution.

Accurate placement of a TCC, crucial for its successful functioning, is difficult because of differences in body shapes. A team of researchers led by Dr. Ohara from Okayama University have now developed a bendable support device that helps placing a TCC on a patient's body - the tool enables making temporary markings on the body, based on which the TCC can be accurately inserted.

Reference 

Toshiaki Ohara, Kazufumi Sakurama, Satoshi Hiramatsu, Toshimasa Karai, Toshiaki Sato, Yuta Nishina. New insertion support device assisted the accurate placement of tunnelled cuffed catheter: first experience of 10 cases. The journal of vascular access, 2018 May 1:1129729818771884.

DOI: 10.1177/1129729818771884.

http://journals.sagepub.com/doi/abs/10.1177/1129729818771884?journalCode=jvaa

Reference (Okayama University e-Bulletin & OU-MRU): Assistant Professor Ohara's team 

OU-MRU Vol.22：Medical supportive device for hemodialysis catheter puncture

OU-MRU Vol.50：Iron removal as a potential cancer therapy

Website: http://www.okayama-u.ac.jp/index_e.html

Okayama Univ. e-Bulletin: http://www.okayama-u.ac.jp/user/kouhou/ebulletin/

About Okayama University (YouTube):

https://www.youtube.com/watch?v=iDL1coqPRYI

Okayama University Image Movie (YouTube):

https://www.youtube.com/watch?v=KU3hOIXS5kk

Okayama University Medical Research Updates （OU-MRU） 

Vol.1：Innovative non-invasive 'liquid biopsy' method to capture circulating tumor cells from blood samples for genetic testing

Vol.2：Ensuring a cool recovery from cardiac arrest

Vol.3：Organ regeneration research leaps forward

Vol.4：Cardiac mechanosensitive integrator

Vol.5：Cell injections get to the heart of congenital defects

Vol.6：Fourth key molecule identified in bone development

Vol.7：Anticancer virus solution provides an alternative to surgery

Vol.8：Light-responsive dye stimulates sight in genetically blind patients

Vol.9：Diabetes drug helps towards immunity against cancer

Vol.10：Enzyme-inhibitors treat drug-resistant epilepsy

Vol.11：Compound-protein combination shows promise for arthritis treatment

Vol.12：Molecular features of the circadian clock system in fruit flies

Vol.13：Peptide directs artificial tissue growth

Vol.14：Simplified boron compound may treat brain tumours

Vol.15：Metamaterial absorbers for infrared inspection technologies

Vol.16：Epigenetics research traces how crickets restore lost limbs

Vol.17：Cell research shows pathway for suppressing hepatitis B virus

Vol.18：Therapeutic protein targets liver disease

Vol.19：Study links signalling protein to osteoarthritis

Vol.20：Lack of enzyme promotes fatty liver disease in thin patients

Vol.21：Combined gene transduction and light therapy targets gastric cancer

Vol.22：Medical supportive device for hemodialysis catheter puncture

Vol.23：Development of low cost oral inactivated vaccines for dysentery

Vol.24：Sticky molecules to tackle obesity and diabetes

Vol.25：Self-administered aroma foot massage may reduce symptoms of anxiety

Vol.26：Protein for preventing heart failure

Vol.27：Keeping cells in shape to fight sepsis

Vol.28：Viral-based therapy for bone cancer

Vol.29：Photoreactive compound allows protein synthesis control with light

Vol.30：Cancer stem cells' role in tumor growth revealed

Vol.31：Prevention of RNA virus replication

Vol.32：Enzyme target for slowing bladder cancer invasion

Vol.33：Attacking tumors from the inside

Vol.34：Novel mouse model for studying pancreatic cancer

Vol.35：Potential cause of Lafora disease revealed

Vol.36：Overloading of protein localization triggers cellular defects

Vol.37：Protein dosage compensation mechanism unravelled

Vol.38：Bioengineered tooth restoration in a large mammal

Vol.39：Successful test of retinal prosthesis implanted in rats

Vol.40：Antibodies prolong seizure latency in epileptic mice

Vol.41：Inorganic biomaterials for soft-tissue adhesion

Vol.42：Potential drug for treating chronic pain with few side effects

Vol.43：Potential origin of cancer-associated cells revealed

Vol.44：Protection from plant extracts

Vol.45：Link between biological-clock disturbance and brain dysfunction uncovered

Vol.46：New method for suppressing lung cancer oncogene

Vol.47：Candidate genes for eye misalignment identified

Vol.48：Nanotechnology-based approach to cancer virotherapy

Vol.49：Cell membrane as material for bone formation

Vol.50：Iron removal as a potential cancer therapy

Vol.51：Potential of 3D nanoenvironments for experimental cancer

Vol.52：A protein found on the surface of cells plays an integral role in tumor growth and sustenance

Vol.53：Successful implantation and testing of retinal prosthesis in monkey eyes with retinal degeneration

Vol.54：Measuring ion concentration in solutions for clinical and environmental research

Vol.55：Diabetic kidney disease: new biomarkers improve the prediction of the renal prognosis

About Okayama University 

Okayama University is one of the largest comprehensive universities in Japan with roots going back to the Medical Training Place sponsored by the Lord of Okayama and established in 1870. Now with 1,300 faculty and 13,000 students, the University offers courses in specialties ranging from medicine and pharmacy to humanities and physical sciences. Okayama University is located in the heart of Japan approximately 3 hours west of Tokyo by Shinkansen.

Website: http://www.okayama-u.ac.jp/index_e.html

Correspondence to
Assistant Professor Toshiaki Ohara, M.D., Ph.D.
Department of Pathology & Experimental Medicine,
Graduate School of Medicine, Dentistry and Pharmaceutical
Sciences, Okayama University, Shikata-cho 2-5-1, Okayama city,
Okayama 700-8558, Japan
E-mail: t_ohara@cc.okayama-u.ac.jp

Further information
Okayama University
1-1-1 Tsushima-naka, Kita-ku , Okayama 700-8530, Japan
Public Relations and Information Strategy
E-mail: www-adm@adm.okayama-u.ac.jp

http://www.okayama-u.ac.jp/user/byouri/pathology-1/TOP.html